Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
N Engl J Med
    May 2023
  1. LEE JM, Choi KH, Song YB, Lee JY, et al
    Intravascular Imaging-Guided or Angiography-Guided Complex PCI.
    N Engl J Med. 2023;388:1668-1679.
    >> Share

    April 2023
  2. ISHANI A, Cushman WC, Leatherman SM
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. Reply.
    N Engl J Med. 2023;388:1342.
    >> Share

  3. FRAVEL MA, Ernst ME
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2023;388:1342.
    >> Share

  4. MESSERLI FH
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2023;388:1341-1342.
    >> Share

    March 2023
  5. JABAGI MJ, Bertrand M, Botton J, Le Vu S, et al
    Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
    N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134.
    >> Share

  6. OLIVA-DAMASO N, Perazella MA
    Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
    N Engl J Med. 2023;388:955.
    >> Share

  7. VAN REGEMORTER E, Jadoul M, Gillion V
    Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
    N Engl J Med. 2023;388:954-955.
    >> Share

  8. KEANEY JF JR
    Bempedoic Acid and the Prevention of Cardiovascular Disease.
    N Engl J Med. 2023 Mar 4. doi: 10.1056/NEJMe2300793.
    >> Share

  9. NISSEN SE, Lincoff AM, Brennan D, Ray KK, et al
    Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
    N Engl J Med. 2023 Mar 4. doi: 10.1056/NEJMoa2215024.
    >> Share

    January 2023
  10. PERERA D, Ryan M, O'Kane PD
    PCI for Ischemic Left Ventricular Dysfunction. Reply.
    N Engl J Med. 2023;388:188-189.
    >> Share

  11. ALFONSO F, Cuesta J, Diez-Villanueva P
    PCI for Ischemic Left Ventricular Dysfunction.
    N Engl J Med. 2023;388:188.
    >> Share

  12. ANDREOTTI F, Chiariello GA, Massetti M
    PCI for Ischemic Left Ventricular Dysfunction.
    N Engl J Med. 2023;388:187-188.
    >> Share

  13. VIDAL-CALES P, Brugaletta S, Sabate M
    PCI for Ischemic Left Ventricular Dysfunction.
    N Engl J Med. 2023;388:187.
    >> Share

  14. DE SILVA K, Campbell T, Kumar S
    PCI for Ischemic Left Ventricular Dysfunction.
    N Engl J Med. 2023;388:186-187.
    >> Share

    December 2022
  15. GUSEH JS 2ND, Parakh A, Chen YE, Sundt TM, et al
    Case 40-2022: A 38-Year-Old Man with Exertional Chest Discomfort.
    N Engl J Med. 2022;387:2450-2460.
    >> Share

  16. MC CAUSLAND FR, Singh AK, Claggett BL, Carroll K, et al
    Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply.
    N Engl J Med. 2022;387:2482-2485.
    >> Share

  17. HUANG C, He Y, Li Y
    Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease.
    N Engl J Med. 2022;387:2482.
    >> Share

  18. ROJAS-RIVERA J, Carriazo S, Ortiz A
    Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease.
    N Engl J Med. 2022;387:2481-2482.
    >> Share

  19. ISHANI A, Cushman WC, Leatherman SM, Lew RA, et al
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2022 Dec 14. doi: 10.1056/NEJMoa2212270.
    >> Share

  20. CASTELLANO JM, Cordero A, Fuster V
    Polypill Strategy in Secondary Cardiovascular Prevention. Reply.
    N Engl J Med. 2022;387:2197-2198.
    >> Share

  21. ZHANG Y, Zhu Z, Gao C
    Polypill Strategy in Secondary Cardiovascular Prevention.
    N Engl J Med. 2022;387:2197.
    >> Share

  22. CARNEY RM, Freedland KE
    Polypill Strategy in Secondary Cardiovascular Prevention.
    N Engl J Med. 2022;387:2197.
    >> Share

  23. STOSCHITZKY K
    Polypill Strategy in Secondary Cardiovascular Prevention.
    N Engl J Med. 2022;387:2196-2197.
    >> Share

    November 2022
  24. PARK DW, Kang DY, Park SJ
    Stress Testing in High-Risk Patients after PCI. Reply.
    N Engl J Med. 2022;387:e54.
    >> Share

  25. SHIOMI H
    Stress Testing in High-Risk Patients after PCI.
    N Engl J Med. 2022;387:e54.
    >> Share

  26. O'DONOGHUE ML, Rosenson RS, Gencer B, Lopez JAG, et al
    Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
    N Engl J Med. 2022 Nov 6. doi: 10.1056/NEJMoa2211023.
    >> Share

  27. DAS PRADHAN A, Glynn RJ, Fruchart JC, MacFadyen JG, et al
    Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
    N Engl J Med. 2022 Nov 5. doi: 10.1056/NEJMoa2210645.
    >> Share


  28. Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2022;387:1724.
    >> Share

    October 2022
  29. DESAI AS, Dudzinski DM, Stib MT, Chen ST, et al
    Case 32-2022: A 76-Year-Old Man with Postoperative Cardiogenic Shock and Diffuse Rash.
    N Engl J Med. 2022;387:1502-1513.
    >> Share

  30. PERERA D, Clayton T, O'Kane PD, Greenwood JP, et al
    Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
    N Engl J Med. 2022;387:1351-1360.
    >> Share

    September 2022

  31. Gliflozins in the Management of Cardiovascular Disease.
    N Engl J Med. 2022;387:1244.
    >> Share

  32. HONDA S, Kawasaki T
    Wellens' Syndrome.
    N Engl J Med. 2022;387:e25.
    >> Share

  33. RYDEN L, Standl E
    After Metformin - Next Steps for Type 2 Diabetes with Low Cardiovascular Risk.
    N Engl J Med. 2022;387:1136-1138.
    >> Share

  34. NATHAN DM, Lachin JM, Bebu I, Burch HB, et al
    Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
    N Engl J Med. 2022;387:1075-1088.
    >> Share

  35. FUKAMACHI D, Okumura Y
    Giant Coronary-Artery Aneurysm.
    N Engl J Med. 2022;387:e23.
    >> Share

  36. PARK DW, Kang DY, Ahn JM, Yun SC, et al
    Routine Functional Testing or Standard Care in High-Risk Patients after PCI.
    N Engl J Med. 2022;387:905-915.
    >> Share

  37. TAMIS-HOLLAND JE
    Surveillance Stress Testing "POST-PCI" - A Future Class III Recommendation?
    N Engl J Med. 2022;387:941-942.
    >> Share

  38. KOO BK, Hu X, Kang J, Zhang J, et al
    Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI.
    N Engl J Med. 2022;387:779-789.
    >> Share

    August 2022
  39. LINDHOLT JS, Sogaard R, Rasmussen LM, Mejldal A, et al
    Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMoa2208681.
    >> Share

  40. CASTELLANO JM, Pocock SJ, Bhatt DL, Quesada AJ, et al
    Polypill Strategy in Secondary Cardiovascular Prevention.
    N Engl J Med. 2022 Aug 26. doi: 10.1056/NEJMoa2208275.
    >> Share

  41. LESLIE BR, Gerwin LE
    Gliflozins in the Management of Cardiovascular Disease.
    N Engl J Med. 2022;387:478.
    >> Share

  42. HEYMAN SN, Abassi Z
    Gliflozins in the Management of Cardiovascular Disease.
    N Engl J Med. 2022;387:477-478.
    >> Share

  43. JACOBS DR JR, Sinaiko AR, Woo JG
    Childhood Risk Factors and Adult Cardiovascular Events. Reply.
    N Engl J Med. 2022;387:473-474.
    >> Share

  44. SCHUERMANS A, Lewandowski AJ
    Childhood Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022;387:473.
    >> Share

  45. WANG M, Zhou M, Feng Z
    Childhood Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022;387:472-473.
    >> Share

  46. ORTIZ A
    Childhood Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022;387:472.
    >> Share

    July 2022
  47. DODD JD, Kofoed KF, Dewey M
    CT or Invasive Coronary Angiography in Stable Chest Pain. Reply.
    N Engl J Med. 2022;387:379-380.
    >> Share

  48. GIBBONS RJ
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022;387:378.
    >> Share

  49. DANZI GB, Piccolo R
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022;387:378.
    >> Share

  50. BAUMANN AA, Roberts-Thomson RL, Psaltis PJ
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022;387:377-378.
    >> Share

  51. REDBERG R, Jeon D
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022;387:376-377.
    >> Share

    June 2022
  52. MA Y, Cook NR, Hu FB
    Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk. Reply.
    N Engl J Med. 2022;386:e60.
    >> Share

  53. IOANNOU A
    Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    N Engl J Med. 2022;386:e60.
    >> Share

  54. LIU L, Chen Y, Liu S
    Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    N Engl J Med. 2022;386:e60.
    >> Share

  55. INOUE K, Nishikawa T
    Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    N Engl J Med. 2022;386:e60.
    >> Share

    May 2022
  56. BRAUNWALD E
    Gliflozins in the Management of Cardiovascular Disease.
    N Engl J Med. 2022;386:2024-2034.
    >> Share

  57. FEARON WF, Zimmermann FM, Pijls NHJ
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. Reply.
    N Engl J Med. 2022;386:1865-1866.
    >> Share

  58. FERLINI M, Munafo A, Visconti LO
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:1865.
    >> Share

  59. FELDMAN D, Nicolas J, Dangas G
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:1864-1865.
    >> Share

  60. ROSENBLUM AL, Pack QR
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:1864.
    >> Share

  61. VAN BELLE E, Patel M, Davies J
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:1863-1864.
    >> Share

  62. YTTERBERG SR, Bhatt DL, Connell CA
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply.
    N Engl J Med. 2022;386:1768.
    >> Share

  63. D'AMICO F, Peyrin-Biroulet L, Danese S
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:1767-1768.
    >> Share

  64. LADAK K, Crowther M
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:1766-1767.
    >> Share

  65. OZDEDE A, Yazici H
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:1766.
    >> Share

    April 2022
  66. PITT B, Joseph A, Schloemer P
    Cardiovascular Events with Finerenone in CKD and Diabetes. Reply.
    N Engl J Med. 2022;386:e43.
    >> Share

  67. ORTIZ A, Sarafidis P, Ferro CJ
    Cardiovascular Events with Finerenone in CKD and Diabetes.
    N Engl J Med. 2022;386:e43.
    >> Share

  68. GERARD AO, Laurain A, Esnault VLM
    Cardiovascular Events with Finerenone in CKD and Diabetes.
    N Engl J Med. 2022;386:e43.
    >> Share

  69. KAO PH, Hsu LC
    Cardiovascular Events with Finerenone in CKD and Diabetes.
    N Engl J Med. 2022;386:e43.
    >> Share

  70. INGELFINGER JR
    Childhood Risk Factors and Prediction of Adult Cardiovascular End Points.
    N Engl J Med. 2022 Apr 4. doi: 10.1056/NEJMe2203743.
    >> Share

  71. JACOBS DR JR, Woo JG, Sinaiko AR, Daniels SR, et al
    Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022 Apr 4. doi: 10.1056/NEJMoa2109191.
    >> Share

    March 2022
  72. MAUROVICH-HORVAT P, Bosserdt M, Kofoed KF, Rieckmann N, et al
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022 Mar 4. doi: 10.1056/NEJMoa2200963.
    >> Share

  73. DEVEREAUX PJ, Lamy A, Chan MTV, Allard RV, et al
    High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality.
    N Engl J Med. 2022;386:827-836.
    >> Share

    February 2022
  74. PFEFFER MA, Jering KS, Braunwald E
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. Reply.
    N Engl J Med. 2022;386:603.
    >> Share

  75. IOANNOU A
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2022;386:603.
    >> Share

    January 2022
  76. YTTERBERG SR, Bhatt DL, Mikuls TR, Koch GG, et al
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:316-326.
    >> Share

  77. FEARON WF, Zimmermann FM, De Bruyne B, Piroth Z, et al
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:128-137.
    >> Share

    December 2021

  78. Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2021;385:2592.
    >> Share

  79. DESCH S, Freund A, Akin I, Behnes M, et al
    Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2021;385:2544-2553.
    >> Share

  80. NEAL B, Tian M, Wu Y
    Salt Substitute and Cardiovascular Events and Death. Reply.
    N Engl J Med. 2021;385:2493-2494.
    >> Share

  81. BURSZTYN M
    Salt Substitute and Cardiovascular Events and Death.
    N Engl J Med. 2021;385:2493.
    >> Share

  82. MORITA H, Komuro I
    Salt Substitute and Cardiovascular Events and Death.
    N Engl J Med. 2021;385:2492-2493.
    >> Share

  83. ZUCCALA G, Laudisio A, Ciaburri M
    Salt Substitute and Cardiovascular Events and Death.
    N Engl J Med. 2021;385:2492.
    >> Share

  84. GRAUDAL N, Jurgens G, Alderman MH
    Salt Substitute and Cardiovascular Events and Death.
    N Engl J Med. 2021;385:2491-2492.
    >> Share

    November 2021
  85. MATHEW R, Di Santo P, Hibbert B
    Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Reply.
    N Engl J Med. 2021;385:2108-2109.
    >> Share

  86. GIBSON LE, Chang MG, Berra L
    Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    N Engl J Med. 2021;385:2108.
    >> Share

  87. POTTER BJ
    Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    N Engl J Med. 2021;385:2107-2108.
    >> Share

  88. MA Y, He FJ, Sun Q, Yuan C, et al
    24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    N Engl J Med. 2021 Nov 13. doi: 10.1056/NEJMoa2109794.
    >> Share

  89. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2021;385:1845-1855.
    >> Share

  90. SINGH AK, Carroll K, McMurray JJV, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113380.
    >> Share

  91. SINGH AK, Carroll K, Perkovic V, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113379.
    >> Share

    October 2021
  92. VALGIMIGLI M, Frigoli E, Heg D, Tijssen J, et al
    Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
    N Engl J Med. 2021;385:1643-1655.
    >> Share


  93. Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2021;385:1632.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016